📰 Small Molecules News
Small Molecules News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Small Molecules. Real-time updates on events, politics, business and more.
June 15, 2024
Press release - InsightAce Analytic Pvt.Ltd - Metaverse in Healthcare Market Training, Treatment, Transformation: The Expanding Applications of Metaverse in Healthcare - published on openPR.com
June 4, 2024
Press release - InsightAce Analytic Pvt.Ltd - Antisense Oligonucleotide Therapeutics Market A New Era of Precision Medicine - published on openPR.com
May 6, 2024
In a study published in the prestigious scientific journal PNAS, Umeå researchers describe a natural product-like molecule, Tantalosin, that inhibits interaction between two proteins in complexes that reshape membranes inside the cell.
April 9, 2024
Simultaneous publication and presentation of RMC-6236 chemical structure, preclinical data and case studies during the “KRAS: Broadening the Attack Beyond...
April 4, 2024
Lonza to manufacture Acumen’s monoclonal antibody, sabirnetug , for clinical development and commercialization, if approvedSabirnetug is the first monoclonal antibody candidate to enter the clinic...
April 4, 2024
Lonza to manufacture Acumen’s monoclonal antibody, sabirnetug (ACU193), for clinical development and commercialization, if approvedSabirnetug is the first monoclonal antibody candidate to enter the clinic developed to selectively target toxic
April 3, 2024
Lonza Group AG / Key word(s): Sustainability/Miscellaneous03-Apr-2024 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR Annual General Meeting will take place on 8 May 2024 at the Co...
March 27, 2024
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The
March 13, 2024
Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a significant decline in short interest in February. As of February 29th, there was short interest totalling 9,100 shares, a decline of 68.1% from the February 14th total of 28,500 shares. Based on an average daily trading volume, of 65,700 shares, the short-interest ratio is currently […]
February 28, 2024
Dubinsky discusses the importance of head-to-head trials in IBD and looks ahead to the use of combination therapy to achieve desired treatment outcomes.